SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-18-002370
Filing Date
2018-03-26
Accepted
2018-03-26 07:06:20
Documents
3
Period of Report
2018-03-26
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K f8-k.htm 8-K 27868
2 EX-99.1 ex-99d1.htm EX-99.1 156424
3 GRAPHIC ex-99d1g001.jpg GRAPHIC 8102
  Complete submission text file 0001558370-18-002370.txt   196728
Mailing Address 100 BEAVER STREET SUITE 201 WALTHAM MA 02453
Business Address 100 BEAVER STREET SUITE 201 WALTHAM MA 02453 781-996-5252
Kala Pharmaceuticals, Inc. (Filer) CIK: 0001479419 (see all company filings)

IRS No.: 270604595 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38150 | Film No.: 18711590
SIC: 2834 Pharmaceutical Preparations